Pasar al contenido principal

Identification of novel therapeutic targets and biomarkers of disease and response to therapy in autoimmune and inflammatory diseases

RYC2021-033828-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CORDOBA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Metabolomic and Machine Learning Enhances Patient Diagnosis and Stratification in Systemic Autoimmune Diseases

  • Perez-Sanchez, Carlos
  • Perez-Campoamor, Antonio
  • Bolón-Canedo, Verónica
[Abstract]: Systemic Autoimmune Diseases (SADs) present clinical challenges due to their heterogeneity, which complicates patient classification, and delays diagnosis. We characterized their metabolomic fingerprints aiming to uncover novel molecular insights and enhance patient stratification and diagnosis through the application of Machine Learning (ML). A total of 716 individuals from the international multicenter study PRECISESADS were included: 272 with Rheumatoid Arthritis (RA), 183 with Systemic Lupus Erythematosus (SLE), 148 with Antiphospholipid Syndrome (APS), 70 with Systemic Sclerosis (SSc), and 43 Healthy Donors (HDs). The circulating metabolomic profile was analyzed using Nuclear Magnetic Resonance (NMR) spectroscopy and a combination of supervised and unsupervised ML methods. Several metabolites were differentially expressed in each disease compared to HDs, with the highest number of alterations observed in SSc (99) and APS (68), followed by SLE (30) and RA (17). The prominent reduction of antioxidant and anti-inflammatory metabolites (albumin and histidine), combined with the increase in the pro-inflammatory marker GlycA, emerged as key shared hallmarks of SADs. Each disease also displayed a distinct set of uniquely altered metabolites. ML demonstrated strong diagnostic potential (AUC 0.79–0.87) by generating disease-specific signatures driven by alterations in lipids, fatty acids, energy metabolism, and amino acid pathways. Unsupervised clustering analysis of the entire cohort identified three distinct clusters, with each disease represented across all clusters in varying proportions, which were strongly associated with distinct key clinical features. This study highlights the utility of metabolomics and ML to classify and stratify patients with SADs, reinforcing their clinical relevance in precision medicine., Supported by CPS: RYC2021-033828-I; PID2022-141500OA-I00; FAR-2024-001 scleromic; and CLP: (PI21/00591, PI21/00959, CD21/00187 and RICOR-21/0002/0033), co-financed by European Union. EU/EFPIA-IMI-PRECISESADS (n° 115565). A.P.C. was supported by STARTQUAKE S.L. and the Spanish Ministry of Science and Innovation cofunding NextGenerationEU (grant number DIN2020-011530). ALU was supported by the Spanish Ministry of Science and Innovation cofunding NextGenerationEU (grant number DIN2022-012766)., España. IMIBIC; FAR-2024-001 scleromic
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Cytochrome b5 reductase 3 overexpression and dietary nicotinamide riboside supplementation promote distinctive mitochondrial alterations in distal convoluted tubules of mouse kidneys during aging

  • Pérez Rodríguez, Miguel
  • García-Verdugo, Alejandro
  • Sánchez-Mendoza, Luz Marina
  • Muñoz-Martín, A.
  • Bolaños, N.
  • Pérez-Sánchez, Carlos
  • Moreno, Juan Antonio
  • Burón, Isabel
  • Cabo, Rafael de
  • González Reyes, José Antonio
  • Villalba Montoro, José Manuel
The kidney undergoes structural and physiological changes with age, predominantly studied in glomeruli and proximal tubules. However, limited knowledge is available about the impact of aging and anti-aging interventions on distal tubules. In this study, we investigated the effects of cytochrome b5 reductase 3 (CYB5R3) overexpression and/or dietary nicotinamide riboside (NR) supplementation on distal tubule mitochondria. Initially, transcriptomic data were analyzed to evaluate key genes related with distal tubules, CYB5R3, and NAD+ metabolism, showing significant differences between males and females in adult and old mice. Subsequently, our emphasis focused on assessing how these interventions, that have demonstrated the anti-aging potential, influenced structural parameters of distal tubule mitochondria, such as morphology and mass, as well as abundance, distance, and length of mitochondria-endoplasmic reticulum contact sites, employing an electron microscopy approach. Our findings indicate that both interventions have differential effects depending on the age and sex of the mice. Aging resulted in an increase in mitochondrial size and a decrease in mitochondrial abundance in males, while a reduction in abundance, size, and mitochondrial mass was observed in old females when compared with their adult counterparts. Combining both the interventions, CYB5R3 overexpression and dietary NR supplementation mitigated age-related changes; however, these effects were mainly accounted by NR in males and by transgenesis in females. In conclusion, the influence of CYB5R3 overexpression and dietary NR supplementation on distal tubule mitochondria depends on sex, genotype, and diet. This underscores the importance of incorporating these variables in subsequent studies to comprehensively address the multifaceted aspects of aging.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Metabolomic and machine learning enhances patient diagnosis and stratification in systemic autoimmune diseases

  • Pérez-Sánchez, Carlos
  • Perez-Campoamor, Antonio
  • García-Delgado, Gema Dolores
  • Vellón-García, Beatriz
  • Llamas Urbano, Adrián
  • Romero-Zurita, Laura
  • Ortiz-Buitrago, Pedro
  • Merlo, Christian
  • Cerdó, Tomás
  • Corrales, Sagrario
  • Sanchez-Pareja, Ismael
  • Muñoz-Barrera, Laura
  • Ábalos-Aguilera, María del Carmen
  • Barbarroja, Nuria
  • Bolón-Canedo, Verónica
  • Ortega-Castro, Rafaela
  • Calvo, Jerusalem
  • Ladehesa-Pineda, Lourdes
  • Aranda-Valera, I. Concepción
  • Beretta, Lorenzo
  • Vigone, Barbara
  • Pers, Jacques‐Olivier
  • Saraux, Alain
  • Devauchelle-Pensec, Valérie
  • Cornec, Divi
  • Jousse‐Joulin, Sandrine
  • Lauwerys, Bernard
  • Ducreux, Julie
  • Maudoux, Anne‐Lise
  • Vasconcelos, Carlos
  • Tavares, Ana
  • Neves, Esmeralda
  • Faria, Raquel
  • Brandão, Mariana
  • Campar, Ana
  • Marinho, António
  • Farinha, Fátima
  • Almeida, Isabel
  • Gonzalez‐Gay Mantecón, Miguel Angel
  • Blanco Alonso, Ricardo
  • Corrales Martínez, Alfonso
  • Cervera, Ricard
  • Rodríguez-Pintó, Ignasi
  • Espinosa, Gerard
  • Lories, Rik
  • De Langhe, Ellen
  • Hunzelmann, Nicolas
  • Belz, Doreen
  • Witte, Torsten
  • Baerlecken, Niklas
  • Stummvoll, Georg
  • Zauner, Michael
  • Lehner, Michaela
  • Collantes Estévez, Eduardo
  • Ortega-Castro, Rafaela
  • Aguirre‐Zamorano, Ma Angeles
  • Escudero-Contreras, Alejandro
  • Castro-Villegas, M. Carmen
  • Ortego-Centeno, Norberto
  • Fernández Roldán, María Concepción
  • Raya, Enrique
  • Jiménez Moleón, Inmaculada
  • De Ramón, Enrique
  • Díaz Quintero, Isabel
  • Meroni, Pier Luigi
  • Gerosa, Maria
  • Schioppo, Tommaso
  • Artusi, Carolina
  • Chizzolini, Carlo
  • Zuber, Aleksandra
  • Wynar, Donatienne
  • Kovács, László
  • Balog, Attila
  • Deák, Magdolna
  • Bocskai, Márta
  • Dulic, Sonja
  • Kádár, Gabriella
  • Hiepe, Falk
  • Gerl, Velia
  • Thiel, Silvia
  • Rodriguez Maresca, Manuel
  • López‐Berrio, Antonio
  • Aguilar‐Quesada, Rocío
  • Navarro‐Linares, Héctor
  • Alarcon-Riquelme, Marta
  • Aguirre, María Ángeles
  • Escudero-Contreras, Alejandro
  • López-Pedrera, Chary
Systemic Autoimmune Diseases (SADs) present clinical challenges due to their heterogeneity, which complicates patient classification, and delays diagnosis. We characterized their metabolomic fingerprints aiming to uncover novel molecular insights and enhance patient stratification and diagnosis through the application of Machine Learning (ML). A total of 716 individuals from the international multicenter study PRECISESADS were included: 272 with Rheumatoid Arthritis (RA), 183 with Systemic Lupus Erythematosus (SLE), 148 with Antiphospholipid Syndrome (APS), 70 with Systemic Sclerosis (SSc), and 43 Healthy Donors (HDs). The circulating metabolomic profile was analyzed using Nuclear Magnetic Resonance (NMR) spectroscopy and a combination of supervised and unsupervised ML methods. Several metabolites were differentially expressed in each disease compared to HDs, with the highest number of alterations observed in SSc (99) and APS (68), followed by SLE (30) and RA (17). The prominent reduction of antioxidant and anti-inflammatory metabolites (albumin and histidine), combined with the increase in the pro-inflammatory marker GlycA, emerged as key shared hallmarks of SADs. Each disease also displayed a distinct set of uniquely altered metabolites. ML demonstrated strong diagnostic potential (AUC 0.79–0.87) by generating disease-specific signatures driven by alterations in lipids, fatty acids, energy metabolism, and amino acid pathways. Unsupervised clustering analysis of the entire cohort identified three distinct clusters, with each disease represented across all clusters in varying proportions, which were strongly associated with distinct key clinical features. This study highlights the utility of metabolomics and ML to classify and stratify patients with SADs, reinforcing their clinical relevance in precision medicine.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications

  • Cerdó, Tomás
  • Woodridge, Laurel
  • Corrales, Sagrario
  • Muñoz-Castañeda, Juan R.
  • Torralbo, Ana Isabel
  • Rahman, Anisur
  • Farinha, Filipa
  • Ortega-Castro, Rafaela
  • Segui, Pedro
  • Sánchez-Pareja, Ismael
  • Muñoz-Barrera, Laura
  • Merlo, Christian
  • Ruiz-Vilchez, Desirée
  • Ábalos-Aguilera, María del Carmen
  • Font-Ugalde, Pilar
  • Barbarroja, Nuria
  • PRECISESADS Clinical Consortium
  • Alarcón-Riquelme, Marta
  • Escudero-Contreras, Alejandro
  • Aguirre-Zamorano, M. Ángeles
  • Pérez-Sánchez, Carlos
  • Jury, Elizabeth C.
  • López-Pedrera, Chary
Objective: Systemic lupus erythematosus (SLE) shows clinical and molecular heterogeneity, and cardiovascular (CV) complications and lupus nephritis (LN) remain leading causes of morbidity and mortality. This study investigated whether omic profiling can reveal molecular endotypes linked to these outcomes. Methods: Serum from 199 patients with SLE underwent proximity extension assay–based proteomics and targeted nuclear magnetic resonance metabolomics. Unsupervised clustering was performed on proteomic data, followed by integrative multiomic factor analysis, logistic regression, and machine learning models. Cohorts with SLE from the University College London, a subset with expanded Olink Reveal panel and untargeted metabolomics, and in vitro (human umbilical vein endothelial cell and HK2) and ex vivo (rat kidneys) models exposed to patient sera were used for validation and mechanistic exploration. Results: Proteomic clustering identified two molecular subgroups (cluster 1 and cluster 2). Compared with cluster 2, cluster 1 showed damage burden and increased rates of LN (1.8-fold), hypertension (3-fold), dyslipidemia (2-fold), obesity (8-fold), and abnormal C-reactive protein/erythrocyte sedimentation rate (4-fold), consistent with CV risk. A total of 47 inflammatory and organ-damage proteins and multiple metabolites were increased in cluster 1. Neural network models based on metabolites and clinical variables discriminated clusters (area under the curve = 0.77), highlighting citrate and lipoproteins as key features. Multiomic analyses and external cohorts confirmed reproducibility and enrichment in pathways related to leukocyte trafficking, endothelial stress, and nephritis. In vitro, serum from patients with SLE induced NF-κB activation in rat kidneys compared with controls, supporting a proinflammatory effect. Conclusion: Multiomic profiling delineates molecular endotypes in SLE, integrating immune, vascular, and metabolic pathways associated with CV risk and LN, supporting their potential for precision risk stratification.